J&J/Cordis Teramed Alliance Suggests Swifter Access To $1 Bil. AAA Market

Johnson & Johnson/Cordis will join a crowded field of players in the worldwide abdominal aortic aneurysm (AAA) market, expected to top $1 bil. by 2008, following the acquisition of privately-held Teramed